Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension
- PMID: 21953487
- PMCID: PMC3212682
- DOI: 10.1007/s11906-011-0230-y
Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension
Abstract
Genetic linkage and association methods have long been the most important tools for gene identification in humans. These approaches can either be hypothesis-based (i.e., candidate-gene studies) or hypothesis-free (i.e., genome-wide studies). The first part of this review offers an overview of the latest successes in gene finding for blood pressure (BP) and essential hypertension using these DNA sequence-based discovery techniques. We further emphasize the importance of post-genome-wide association study (post-GWAS) analysis, which aims to prioritize genetic variants for functional follow-up. Whole-genome next-generation sequencing will eventually be necessary to provide a more comprehensive picture of all DNA variants affecting BP and hypertension. The second part of this review discusses promising novel approaches that move beyond the DNA sequence and aim to discover BP genes that are differentially regulated by epigenetic mechanisms, including microRNAs, histone modification, and methylation.
Figures
References
-
- Nolte IM, McCaffery JM, Snieder H. Candidate gene and genome-wide association studies in behavioral medicine. In: Steptoe A, editor. Handbook of behavioral medicine: Methods and applications. New York: Springer; 2010. pp. 423–441.
-
- Hindorff LA, Junkins HA, Mehta JP, Manolio TA: A catalog of published Genome-Wide Association Studies. Available at: www.genome.gov/gwastudies Accessed in July 2011.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
